Comparative Effectiveness of Myofacial Release vs Cupping Therapy on Quality of Life in Restless Leg Syndrome With Knee O.A.

Launched by DOW UNIVERSITY OF HEALTH SCIENCES · Apr 8, 2025

Keywords

ClinConnect Summary

This clinical trial is exploring how two different treatments—Myofascial Release and Cupping Therapy—can improve the quality of life for people suffering from Restless Leg Syndrome (RLS) along with knee osteoarthritis (OA). The study will take place at the Dow Institute of Physical Medicine and Rehabilitation and aims to find out which therapy might be more effective in relieving symptoms and enhancing sleep quality for participants aged 40 to 70 who have been diagnosed with knee OA and meet specific criteria for RLS.

To participate, individuals should have mild to moderate knee OA and not have any cognitive issues, severe psychiatric conditions, or other serious health problems. If selected, participants will be randomly assigned to one of two groups: one will receive Myofascial Release therapy, while the other will undergo Cupping Therapy, alongside standard treatments like gentle stretching and cooling of the legs. The study will last for four weeks, with a total of 12 treatment sessions, and participants will be assessed before and after the treatments to see how their symptoms have changed.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. grade 2, 3 and 4 knee OA by the Kellgren Lawrence classification
• • 2. Bilateral or unilateral both knee OA
• • 3. Age 40 to 70 years
• • 4. Patients who were meeting the International Restless Leg Syndrome Study Group (IRLSSG) eligibility criteria
• Exclusion Criteria:
• • 1. patients with cognitive dysfunction
• • 2. Rheumatoid arthritis
• • 3. patients with neurological disorders
• • 4. Medical conditions covering (cardiovascular disease, neurological disorders, severe psychiatric illness or pregnancy)